Growth of Healthy Term Infants Fed Formula Containing DHA-B

Completed · Not applicable

Conditions studied: Growth, Tolerance, Infant Development

In brief

The primary objective is to determine if the weight gain of healthy term infants fed a commercially available term infant formula supplemented with DHASCO® is similar to that of infants fed the same formula supplemented with a new product, DHASCO®-B.

Key facts

Study ID

NCT02144402

Run by

dsm-firmenich Switzerland AG

People needed

159

Starts

2014-05-01

Expected to finish

2015-07-01

Last updated by the study team

2015-08-04

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• full term infant (gestational age 37-42 weeks)
• birth weight > or equal to 2500 g
• singleton infant < or equal to 14 days of age in good health
• parent must be >21 years of age
• parental consent

You may not qualify if…

• congenital malformation or genetic disorder
• metabolic anomalies
• maternal infectious diseases, alcoholism, substance abuse
• mothers with gestational diabetes
• participation in another clinical study

Where it is running

• Claude Ashley, MD — Dothan, Alabama, United States
• JBRKIDS — Jonesboro, Arkansas, United States
• Norwich Pediatric — Norwich, Connecticut, United States
• Score Physician Alliance — St. Petersburg, Florida, United States
• Atlantic Clinical Research — Wellington, Florida, United States
• Pedia Research — Newburgh, Indiana, United States
• Heartland Research — Wichita, Kansas, United States
• Stephen Kasparian — Fall River, Massachusetts, United States
• MCHRI — Lincoln, Nebraska, United States
• Ohio Pediatric Research — Dayton, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.